Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Requesting deletion closes your account permanently and prevents your data from being used in further research (existing ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Fundsmith Equity fell off Interactive Investor's most-bought list as tech funds begin to drop in popularity among retail ...

The Hwange Medical Company's School of Nursing proudly celebrated the graduation of 31 trainees who received diplomas in ...

pence - 'neutral' LBBW cuts GSK price target to 1,650 (1,750) pence - 'buy' Deutsche Bank cuts Smith & Nephew to 'hold' (buy) - price target 1,250 (1,350) pence Barclays cuts Smith & Nephew price ...

Friends often repeated his ‘Chris-isms”. Chris retired from Glaxo Smith Kline Pharmaceutical in 2021 after 26 years, leaving a lasting impact on his colleagues. After Alabama crushed Auburn in ...

Constellation Energy is preparing to restart what's now called the Crane Clean Energy Center on Three Mile Island to supply ...

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...